Tumor marker carbohydrate antigen 125 predicts adverse outcome after transcatheter aortic valve implantation

JACC: Cardiovascular Interventions

Volumn 6, Issue 5, 2013, Pages 487-496

  Husser, Oliver ^a,b   Núñez, Julio ^c   Núñez, Eduardo ^c   Holzamer, Andreas ^d   Camboni, Daniele ^d   Luchner, Andreas ^a   Sanchis, Juan ^c   Bodi, Vicente ^c   Riegger, Günter A J ^a   Schmid, Christof ^d   Hilker, Michael ^d   Hengstenberg, Christian ^a,b  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^d UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

biomarker; CA125; joint modeling; prognosis; transcatheter aortic valve implantation

Indexed keywords

CA 125 ANTIGEN; CARBOHYDRATE ANTIGEN;

ADULT; ADVERSE OUTCOME; AGED; AORTA STENOSIS; ARTICLE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EUROSCORE; FEMALE; FOLLOW UP; HAZARD RATIO; HEART FAILURE; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW YORK HEART ASSOCIATION CLASS; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; CA-125 ANTIGEN; CARDIAC CATHETERIZATION; CARDIOVASCULAR DISEASES; FEMALE; HEART FAILURE; HEART VALVE PROSTHESIS IMPLANTATION; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MEMBRANE PROTEINS; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84877967668     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2013.02.006     Document Type: Article

References (31)

1. M.B. Leon, C.R. Smith, M. Mack Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med 363 2010 1597 1607
2. C.R. Smith, M.B. Leon, M.J. Mack Transcatheter versus surgical aortic-valve replacement in high-risk patients N Engl J Med 364 2011 2187 2198
3. R. Pfister, T. Wahlers, F.M. Baer, M. Scherner, J. Strauch, E. Erdmann Utility of NT-pro-BNP in patients undergoing transapical aortic valve replacement Clin Res Cardiol 99 2010 301 307
4. J. Kefer, C. Beauloye, P. Astarci Usefulness of B-type natriuretic peptide to predict outcome of patients treated by transcatheter aortic valve implantation Am J Cardiol 106 2010 1782 1786
5. K. Spargias, S. Polymeros, A. Dimopoulos The predictive value and evolution of N-terminal pro-B-type natriuretic peptide levels following transcutaneous aortic valve implantation J Interv Cardiol 24 2011 462 469
6. I. Kubonishi, K. Bandobashi, N. Murata High serum levels of CA125 and interleukin-6 in a patient with ki-1 lymphoma Br J Haematol 98 1997 450 452
7. G. Minana, J. Nunez, J. Sanchis, V. Bodi, E. Nunez, A. Llacer CA125 and immunoinflammatory activity in acute heart failure Int J Cardiol 145 2010 547 548
8. J. Núñez, E. Núñez, L. Consuegra Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure? Heart 93 2007 716 721
9. J. Núñez, J. Sanchis, V. Bodí Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure Eur Heart J 31 2010 1752 1763
10. A. D'Aloia, P. Faggiano, G. Aurigemma Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis J Am Coll Cardiol 41 2003 1805 1811
11. F. Antonini-Canterin, B.A. Popescu, A.C. Popescu Heart failure in patients with aortic stenosis: clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement Int J Cardiol 128 2008 406 412
12. M.B. Leon, N. Piazza, E. Nikolsky Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium J Am Coll Cardiol 57 2011 253 269
13. P. Royston, P. Lambert Flexible Parametric Survival Analysis Using Stata: Beyond the Cox Model 2011 Stata Press College Station, TX
14. D. Rizopoulos Joint models for longitudinal and time-to-event data: with applications in R2012 Chapman & Hall/CRC Biostatistics Series 2012 CRC Press Boca Raton, FL
15. J.G. Ibrahim, H. Chu, L.M. Chen Basic concepts and methods for joint models of longitudinal and survival data J Clin Oncol 28 2010 2796 2801
16. D. Rizopoulos, D. Huard, C.J. Fonnesbeck JM: an R package for the joint modelling of longitudinal and time-to-event data J Stat Softw 35 2010 1 33
17. S.K. Kodali, M.R. Williams, C.R. Smith Two-year outcomes after transcatheter or surgical aortic-valve replacement N Engl J Med 366 2012 1686 1695
18. M. Gilard, H. Eltchaninoff, B. Iung Registry of transcatheter aortic-valve implantation in high-risk patients N Engl J Med 366 2012 1705 1715
19. S.A. Nashef, F. Roques, P. Michel, E. Gauducheau, S. Lemeshow, R. Salamon European system for cardiac operative risk evaluation (EuroSCORE) Eur J Cardiothorac Surg 16 1999 9 13
20. S.M. O'Brien, D.M. Shahian, G. Filardo The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2 - isolated valve surgery Ann Thorac Surg 88 2009 S23 S42
21. W. Qi, P. Mathisen, J. Kjekshus Natriuretic peptides in patients with aortic stenosis Am Heart J 142 2001 725 732
22. P. Lim, J.L. Monin, M. Monchi Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide Eur Heart J 25 2004 2048 2053
23. J. Bergler-Klein, U. Klaar, M. Heger Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis Circulation 109 2004 2302 2308
24. E.R. Levin, D.G. Gardner, W.K. Samson Natriuretic peptides N Engl J Med 339 1998 321 328
25. J. Rodés-Cabau, M. Gutiérrez, R. Bagur Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation J Am Coll Cardiol 57 2011 1988 1999
26. M. Gheorghiade, F. Follath, P. Ponikowski Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine Eur J Heart Fail 12 2010 423 433
27. G. Torre-Amione Immune activation in chronic heart failure Am J Cardiol 95 2005 3C 8C discussion 38C-40C
28. G. Miñana Escrivá, J. Núñez, J. Sanchis [Carbohydrate antigen 125 serial measurements after an admission for acute heart failure and risk of early readmission] [Spanish] Med Clin (Barc) 139 2012 479 486
29. J. Núñez, E. Núñez, J. Sanchis Antigen carbohydrate 125 and brain natriuretic peptide serial measurements for risk stratification following an episode of acute heart failure Int J Cardiol 159 2012 21 28
30. E. Varol, M. Ozaydin, A. Dogan, F. Kosar Tumour marker levels in patients with chronic heart failure Eur J Heart Fail 7 2005 840 843
31. J.M. Bidart, F. Thuillier, C. Augereau Kinetics of serum tumor marker concentrations and usefulness in clinical monitoring Clin Chem 45 1999 1695 1707